Advisors Preferred, LLC Novo Nordisk A S Transaction History

Advisors Preferred, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$122.71 - $146.91 $73,994 - $88,586	603 New	603 $86,000
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $3,423 - $4,112	-39 Reduced 36.79%	67 $6,000
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $2,637 - $5,786	29 Added 37.66%	106 $9,000
Q1 2023 May 03, 2023	SELL	$132.34 - $159.14 $6,352 - $7,638	-48 Reduced 38.4%	77 $12,000
Q4 2022 Feb 08, 2023	BUY	$102.55 - $135.33 $12,818 - $16,916	125 New	125 $16,000
Q1 2020 Apr 20, 2020	SELL	$49.46 - $64.78 $88,879 - $116,409	-1,797 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$49.86 - $58.26 $74,790 - $87,390	1,500 Added 505.05%	1,797 $104,000
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $9,412 - $10,579	-198 Reduced 40.0%	297 $15,000
Q2 2019 Aug 06, 2019	BUY	$46.79 - $52.47 $23,161 - $25,972	495 New	495 $26,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $188B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.